Apellis Announces Pegcetacoplan Maa Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
Apellis宣佈歐洲藥品管理局(EMA)對Pegcetacoplan Maa的審查已重置爲初步評估的第180天
Apellis Announces Pegcetacoplan Maa Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
Apellis宣佈歐洲藥品管理局(EMA)對Pegcetacoplan Maa的審查已重置爲初步評估的第180天
使用瀏覽器的分享功能,分享給你的好友吧